about
Anti-inflammatory preconditioning by agonists of adenosine A1 receptorAdmission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive careAdmission cell free DNA as a prognostic factor in burns: quantification by use of a direct rapid fluorometric technique.Cell-free DNA and telomere length among women undergoing in vitro fertilization treatmentT lymphocytes: the "cellular" arm of acquired immunity in the peritoneum.Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries.Cell-free deoxyribonucleic acid as a prognostic marker of bowel ischemia in patients with small bowel obstruction.Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor.Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.Elevated Cell-Free DNA Measured by a Simple Assay Is Associated With Increased Rate of Colorectal Cancer Relapse.Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer.Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium.Regulation of adenosine system at the onset of peritonitis.Involvement of graft-derived interleukin-15 in islet allograft rejection in mice.Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients.A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids.Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models.Ketamine improves survival and suppresses IL-6 and TNFalpha production in a model of Gram-negative bacterial sepsis in rats.Renal cells express a functional interleukin-15 receptor.Correction of anemia in uremic mice by genetically modified peritoneal mesothelial cells.Ketamine delays mortality in an experimental model of hemorrhagic shock and subsequent sepsis.Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing.Involvement of adenosine in the antiinflammatory action of ketamine.Circulating Cell-Free DNA Levels in Patients with Metastatic Renal Cell Carcinoma.Ketamine improves survival in burn injury followed by sepsis in rats.The effect of a high partial pressure of carbon dioxide environment on metabolism and immune functions of human peritoneal cells-relevance to carbon dioxide pneumoperitoneum.Increased plasma cell-free DNA is associated with low pregnancy rates among women undergoing IVF-embryo transfer.Systemic inflammatory response syndrome-related lymphopenia is associated with adenosine A1 receptor dysfunction.Association between renal injury and reduced interleukin-15 and interleukin-15 receptor levels in acute kidney injury.Measurement of circulating cell-free DNA levels by a simple fluorescent test in patients with breast cancer.CD40 ligand expression correlates with resolution of peritonitis and mononuclear cell recruitment.Erythropoietin prevents dialysis fluid-induced apoptosis of mesothelial cells.Decrease in cell free DNA levels following participation in stress reduction techniques among women undergoing infertility treatmentDifferent regulatory levels are involved in the generation of hemopoietic cytokines (CSFs and IL-6) in fibroblasts stimulated by inflammatory productsRegulation of interleukin 1 generation in immune-activated fibroblastsAn early rise in urine N-telopeptide predicts the growth response of normal prepubertal short children to growth hormone therapyAccessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growthFluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladderAdenosine in burn blister fluid
P50
Q21144315-4C1AAF50-55F2-4D49-8D07-F3E938A0C692Q33793544-4D7F5C70-E43A-4E9C-BEAD-8244A669E019Q33876451-CF4D0A25-31C6-41E5-AE16-70289894A20CQ36297219-5F43C7FA-CC23-41F1-945B-EF60403A2B3AQ36553310-FF36C85B-BD49-424A-8309-D9417D75D83CQ37506270-98132EFF-7567-4E45-9702-07F9E6048F64Q37724919-D88585D8-35A8-4CA5-AC81-4FB447555C42Q38630085-B3671186-E1AC-4025-8A59-8799010B1BFBQ38841915-0439A69D-774F-4E59-9F14-7EDC311216B0Q40314032-734CF5C6-D96D-4FD1-9EAC-44956A840625Q40716508-C7511520-3CB5-47E9-ACE2-7586BA39ACD3Q41614253-06E0A74E-90F7-4C5E-80BF-EADCB43B5942Q41836951-CB2824C2-0827-44D5-994D-CEC467A3E900Q42461968-56C6F039-F6A2-4CDF-A0AE-E6D26AB66580Q42801410-DB4809AC-4BF1-4487-972C-3CCD84CCC18BQ42936487-FE01E627-78FE-4532-8119-2BC5246ED20EQ43619042-9FFCBF82-7B91-419A-871B-DABDF2ABF827Q44147553-C4D9445F-7FB5-4DE2-8E3A-5B145868408CQ45007364-EF464F77-FA69-4BE4-8A85-6ECC50F4A7FEQ45238621-C4A7FEAB-A813-470F-A871-6F0D4D31A790Q45862352-E6BCD541-5E24-4017-9678-7BB4C9368647Q45994188-FA25F686-B167-4029-8A02-9D5E3F1F92BFQ46320508-B3F6059A-77A1-4E9A-A107-E2ECF68C39DFQ46508816-88A5FAE1-E333-4377-95C3-F9B15C8BA257Q47728643-4F3E4707-545F-4371-A08E-35540AD476ABQ48679948-F93ADD62-E44A-4311-BA68-C7998F032648Q50521184-72E6C9B6-C700-4E55-8A06-E1E8D6FDCF32Q50893844-2187D03C-7CEE-4ACA-A39D-5280F484831FQ51007514-44885C9A-4C57-4F84-BBE3-312004A24CFCQ53356439-AA322D5C-2478-438E-97AF-43B7C93FB87BQ53667912-273A51F9-20B8-40CE-B7C1-6F1A94362FEFQ54483282-708120E5-ED4C-42DA-AE81-4ACA2EEF2203Q54509135-FA6DAAF0-BB9A-465D-A1AC-DB783E95E946Q61793123-2CAC3C40-A204-4716-ABF4-54145E9B2DFCQ61910211-08997F51-1F62-4458-8A5A-C73856415C55Q61910212-768F7621-5330-4981-AFC2-705BC873AD76Q71876934-64702669-6BBD-49B2-A492-F274FF7768EBQ73395930-F39F5284-88EB-4CC3-A369-FEEDA7E5C04EQ76368230-3BC7E3EC-6383-46A7-B2FF-24694972615AQ79595656-3EB2F99A-2B5A-418D-BE94-2028C962793F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Amos Douvdevani
@ast
Amos Douvdevani
@en
Amos Douvdevani
@es
Amos Douvdevani
@nl
Amos Douvdevani
@sl
type
label
Amos Douvdevani
@ast
Amos Douvdevani
@en
Amos Douvdevani
@es
Amos Douvdevani
@nl
Amos Douvdevani
@sl
prefLabel
Amos Douvdevani
@ast
Amos Douvdevani
@en
Amos Douvdevani
@es
Amos Douvdevani
@nl
Amos Douvdevani
@sl
P106
P1153
7004328349
P31
P496
0000-0002-0197-6481